Brazil is already struggling to cope with the virus, with almost 13 million cases and more than 330,000 deaths. The P.1 strain previously identified is estimatd to be between 1.4 and 2.2 times more transmissible than the original virus.
There is already a P.2 variant, and preliminary research authored by scientists including those at Brazil’s Department of Virology suggests the virus is continuing to alter itself in Brazil, deleting sites on the spike protein which antibodies bind to in a development which would prevent vaccines from working.
The report has not yet been been peer-reviewed – but highlighted the uncertainty of the current situation.
Brazil is currently recording roughly a quarter of all COVID-19 deaths – despite being home to less than three percent of the world’s population.
The Amazonian city of Manaus is one of the hardest hit regions of the country.
William Hanage, an epidemiologist at the Harvard T. H. Chan School of Public Heath, told Scientific American: “It’s quite hard to come up with any scenario that can be made to fit Manaus which is not hugely concerning.
“Following the tragedy of Manaus, I would hope we can put an end to discussion of controlling the pandemic through herd immunity acquired from natural infection.”
Dan Barouch, an immunologist at Harvard University, commented: “These viral variants provide a very strong argument for accelerating the vaccine campaign throughout the world because only with vaccination will we be able to control the pandemic and stop the emergence of new viral variants.
“And viral variants in the future, potentially, will be even more problematic than the ones we have today.”
(More to follow)